{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:34:50Z","timestamp":1787020490972,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The burden of atrial fibrillation (AF) in the intensive care unit (ICU) remains heavy. Glycaemic control is important in the AF management. Glycaemic variability (GV), an emerging marker of glycaemic control, is associated with unfavourable prognosis, and abnormal GV is prevalent in ICUs. However, the impact of GV on the prognosis of AF patients in the ICU remains uncertain. This study aimed to evaluate the relationship between GV and all-cause mortality after ICU admission at short-, medium-, and long-term intervals in AF patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data was obtained from the Medical Information Mart for Intensive Care IV 3.0 database, with admissions (2008\u20132019) as primary analysis cohort and admissions (2020\u20132022) as external validation cohort. Multivariate Cox proportional hazards models, and restricted cubic spline analyses were used to assess the associations between GV and mortality outcomes. Subsequently, GV and other clinical features were used to construct machine learning (ML) prediction models for 30-day all-cause mortality after ICU admission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The primary analysis cohort included 8989 AF patients (age 76.5 [67.7\u201384.3] years; 57.8% male), while the external validation cohort included 837 AF patients (age 72.9 [65.3\u201380.2] years; 67.4% male). Multivariate Cox proportional hazards models revealed that higher GV quartiles were associated with higher risk of 30-day (Q3: HR 1.19, 95%CI 1.04\u20131.37; Q4: HR 1.33, 95%CI 1.16\u20131.52), 90-day (Q3: HR 1.25, 95%CI 1.11\u20131.40; Q4: HR 1.34, 95%CI 1.29\u20131.50), and 360-day (Q3: HR 1.21, 95%CI 1.09\u20131.33; Q4: HR 1.33, 95%CI 1.20\u20131.47) all-cause mortality, compared with lowest GV quartile. Moreover, our data suggests that GV needs to be contained within 20.0%. Among all ML models, light gradient boosting machine had the best performance (internal validation: AUC [0.780], G-mean [0.551], F1-score [0.533]; external validation: AUC [0.788], G-mean [0.578], F1-score [0.568]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>GV is a significant predictor of ICU short-term, mid-term, and long-term all-cause mortality in patients with AF (the potential risk stratification threshold is 20.0%). ML models incorporating GV demonstrated high efficiency in predicting short-term mortality and GV was ranked anterior in importance. These findings underscore the potential of GV as a valuable biomarker in guiding clinical decisions and improving patient outcomes in this high-risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-024-02521-7","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T05:13:39Z","timestamp":1732598019000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Prognostic value of glycaemic variability for mortality in critically ill atrial fibrillation patients and mortality prediction model using machine learning"],"prefix":"10.1186","volume":"23","author":[{"given":"Yang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengkun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Gue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry","family":"McDowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"key":"2521_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k1453","volume":"361","author":"L Staerk","year":"2018","unstructured":"Staerk L, Wang B, Preis SR, Larson MG, Lubitz SA, Ellinor PT, McManus DD, Ko D, Weng L-C, Lunetta KL, Frost L, Benjamin EJ, Trinquart L. Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study. BMJ. 2018;361: k1453.","journal-title":"BMJ"},{"issue":"35","key":"2521_CR2","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","volume":"34","author":"BP Krijthe","year":"2013","unstructured":"Krijthe BP, Kunst A, Benjamin EJ, Lip GYH, Franco OH, Hofman A, Witteman JCM, Stricker BH, Heeringa J. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34(35):2746\u201351.","journal-title":"Eur Heart J"},{"issue":"5","key":"2521_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, Boriani G, Castella M, Dan G-A, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau J-P, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"issue":"5","key":"2521_CR4","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1097\/CCM.0000000000002325","volume":"45","author":"TJ Moss","year":"2017","unstructured":"Moss TJ, Calland JF, Enfield KB, Gomez-Manjarres DC, Ruminski C, DiMarco JP, Lake DE, Moorman JR. New-onset atrial fibrillation in the critically Ill. Crit Care Med. 2017;45(5):790\u20137.","journal-title":"Crit Care Med"},{"issue":"9","key":"2521_CR5","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1097\/CCM.0000000000005883","volume":"51","author":"M Wetterslev","year":"2023","unstructured":"Wetterslev M, Hylander M\u00f8ller M, Granholm A, Hassager C, Haase N, Lange T, Myatra SN, H\u00e4stbacka J, Arabi YM, Shen J, Cronhjort M, Lindqvist E, Aneman A, Young PJ, Szczeklik W, Siegemund M, Koster T, Aslam TN, Bestle MH, Girkov MS, Kalvit K, Mohanty R, Mascarenhas J, Pattnaik M, Vergis S, Haranath SP, Shah M, Joshi Z, Wilkman E, Reinikainen M, Lehto P, Jalkanen V, Pulkkinen A, An Y, Wang G, Huang L, Huang B, Liu W, Gao H, Dou L, Li S, Yang W, Tegnell E, Knight A, Czuczwar M, Czarnik T, Perner A. Atrial fibrillation (AFIB) in the ICU: incidence, risk factors, and outcomes: the international AFIB-ICU Cohort study. Crit Care Med. 2023;51(9):1124\u201337.","journal-title":"Crit Care Med"},{"issue":"3","key":"2521_CR6","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jcrc.2011.10.011","volume":"27","author":"S Kanji","year":"2012","unstructured":"Kanji S, Williamson DR, Yaghchi BM, Albert M, McIntyre L. Epidemiology and management of atrial fibrillation in medical and noncardiac surgical adult intensive care unit patients. J Crit Care. 2012;27(3):e1-8.","journal-title":"J Crit Care"},{"issue":"4","key":"2521_CR7","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jcrc.2014.03.029","volume":"29","author":"SS Makrygiannis","year":"2014","unstructured":"Makrygiannis SS, Margariti A, Rizikou D, Lampakis M, Vangelis S, Ampartzidou OS, Katsifa K, Tselioti P, Foussas SG, Prekates AA. Incidence and predictors of new-onset atrial fibrillation in noncardiac intensive care unit patients. J Crit Care. 2014;29(4):e1\u20135.","journal-title":"J Crit Care"},{"issue":"5","key":"2521_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1177\/0310057X0703500508","volume":"35","author":"S Arora","year":"2007","unstructured":"Arora S, Lang I, Nayyar V, Stachowski E, Ross DL. Atrial fibrillation in a tertiary care multidisciplinary intensive care unit\u2013incidence and risk factors. Anaesth Intensive Care. 2007;35(5):707\u201313.","journal-title":"Anaesth Intensive Care"},{"issue":"1","key":"2521_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/SHK.0000000000002149","volume":"60","author":"S Li","year":"2023","unstructured":"Li S, Yang Q, Wu P, Lu Y, Yang Z, Jiang L. heart rate variability parameters were not associated with 30-Day all-cause mortality in intensive care unit patients with or without atrial fibrillation: a retrospective study of the mimic-IV database. Shock (Augusta, Ga). 2023;60(1):24\u201333.","journal-title":"Shock (Augusta, Ga)"},{"issue":"9785","key":"2521_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(11)60679-X","volume":"378","author":"G Danaei","year":"2011","unstructured":"Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang Y-H, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2\u00b77 million participants. Lancet (London, England). 2011;378(9785):31\u201340.","journal-title":"Lancet (London, England)"},{"issue":"3","key":"2521_CR11","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2337\/dc09-1740","volume":"33","author":"T Duning","year":"2010","unstructured":"Duning T, van den Heuvel I, Dickmann A, Volkert T, Wempe C, Reinholz J, Lohmann H, Freise H, Ellger B. Hypoglycemia aggravates critical illness-induced neurocognitive dysfunction. Diabetes Care. 2010;33(3):639\u201344.","journal-title":"Diabetes Care"},{"issue":"6","key":"2521_CR12","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1097\/CCM.0b013e3181de562c","volume":"38","author":"J Hermanides","year":"2010","unstructured":"Hermanides J, Bosman RJ, Vriesendorp TM, Dotsch R, Rosendaal FR, Zandstra DF, Hoekstra JBL, DeVries JH. Hypoglycemia is associated with intensive care unit mortality. Crit Care Med. 2010;38(6):1430\u20134.","journal-title":"Crit Care Med"},{"issue":"6","key":"2521_CR13","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1177\/193229680800200618","volume":"2","author":"L Monnier","year":"2008","unstructured":"Monnier L, Colette C, Owens DR. Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J Diabetes Sci Technol. 2008;2(6):1094\u2013100.","journal-title":"J Diabetes Sci Technol."},{"issue":"14","key":"2521_CR14","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1001\/jama.295.14.1707","volume":"295","author":"M Brownlee","year":"2006","unstructured":"Brownlee M, Hirsch IB. Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA. 2006;295(14):1707\u20138.","journal-title":"JAMA"},{"issue":"14","key":"2521_CR15","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","volume":"295","author":"L Monnier","year":"2006","unstructured":"Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol J-P, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681\u20137.","journal-title":"JAMA"},{"issue":"3","key":"2521_CR16","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/CCM.0b013e3181cc4be9","volume":"38","author":"J Hermanides","year":"2010","unstructured":"Hermanides J, Vriesendorp TM, Bosman RJ, Zandstra DF, Hoekstra JB, Devries JH. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38(3):838\u201342.","journal-title":"Crit Care Med"},{"issue":"2","key":"2521_CR17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/00000542-200608000-00006","volume":"105","author":"M Egi","year":"2006","unstructured":"Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006;105(2):244\u201352.","journal-title":"Anesthesiology"},{"issue":"1","key":"2521_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12933-022-01473-0","volume":"21","author":"AS Papazoglou","year":"2022","unstructured":"Papazoglou AS, Kartas A, Moysidis DV, Tsagkaris C, Papadakos SP, Bekiaridou A, Samaras A, Karagiannidis E, Papadakis M, Giannakoulas G. Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation. Cardiovasc Diabetol. 2022;21(1):39.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2521_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13098-024-01401-0","volume":"16","author":"Y Fu","year":"2024","unstructured":"Fu Y, Wei X, Cong X, Guifu W. Independent effects of the glucose-to-glycated hemoglobin ratio on mortality in critically ill patients with atrial fibrillation. Diabetol Metab Syndr. 2024;16(1):171.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"2521_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","volume":"10","author":"AEW Johnson","year":"2023","unstructured":"Johnson AEW, Bulgarelli L, Shen L, Gayles A, Shammout A, Horng S, Pollard TJ, Hao S, Moody B, Gow B, Lehman L-WH, Celi LA, Mark RG. MIMIC-IV, a freely accessible electronic health record dataset. Sci Data. 2023;10(1):1.","journal-title":"Sci Data"},{"issue":"5","key":"2521_CR21","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1007\/s10620-024-08295-y","volume":"69","author":"Y Chen","year":"2024","unstructured":"Chen Y, Chen Y, Ming L, Shiyun T. Red blood cell distribution width as a risk factor for 30\/90-day mortality in patients with gastrointestinal bleeding: analysis of the MIMIC-IV database. Dig Dis Sci. 2024;69(5):1740\u201354.","journal-title":"Dig Dis Sci"},{"key":"2521_CR22","doi-asserted-by":"publisher","first-page":"1295377","DOI":"10.3389\/fimmu.2023.1295377","volume":"14","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, Chen Y, Mao M, Wang R, Zhu J, He Q. Association of inflammatory indicators with intensive care unit mortality in critically ill patients with coronary heart disease. Front Immunol. 2023;14:1295377.","journal-title":"Front Immunol"},{"issue":"6","key":"2521_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2023.101488","volume":"49","author":"L Monnier","year":"2023","unstructured":"Monnier L, Bonnet F, Colette C, Renard E, Owens D. Key indices of glycaemic variability for application in diabetes clinical practice. Diabetes Metab. 2023;49(6): 101488.","journal-title":"Diabetes Metab"},{"key":"2521_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7961","volume":"345","author":"T Moore","year":"2012","unstructured":"Moore T, Hennessy EM, Myles J, Johnson SJ, Draper ES, Costeloe KL, Marlow N. Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies. BMJ. 2012;345: e7961.","journal-title":"BMJ"},{"key":"2521_CR25","doi-asserted-by":"publisher","first-page":"1168892","DOI":"10.3389\/fnagi.2023.1168892","volume":"15","author":"X Wang","year":"2023","unstructured":"Wang X, Zhang J, Chen C, Lu Z, Zhang D, Li S. The association between physical activity and cognitive function in the elderly in rural areas of northern China. Front Aging Neurosci. 2023;15:1168892.","journal-title":"Front Aging Neurosci"},{"key":"2521_CR26","unstructured":"Mouri M, Badireddy M. Hyperglycemia. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC; 2024."},{"key":"2521_CR27","unstructured":"Mathew P, Thoppil D. Hypoglycemia. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC; 2024."},{"issue":"1","key":"2521_CR28","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/rheumatology\/keab305","volume":"61","author":"W Wu","year":"2021","unstructured":"Wu W, Xu W, Sun W, Zhang D, Zhao J, Luo Q, Wang X, Zhu F, Zheng Y, Xue Y, Wan W, Wu H, Han Q, Ye S. Forced vital capacity predicts the survival of interstitial lung disease in anti-MDA5 positive dermatomyositis: a multi-centre cohort study. Rheumatology (Oxford). 2021;61(1):230\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"2521_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2024.102456","volume":"49","author":"Y Chen","year":"2024","unstructured":"Chen Y, Gue Y, Calvert P, Gupta D, McDowell G, Azariah JL, Namboodiri N, Bucci T, Jabir A, Tse HF, Chao T-F, Lip GYH, Bahuleyan CG. Predicting stroke in Asian patients with atrial fibrillation using machine learning: a report from the KERALA-AF registry, with external validation in the APHRS-AF registry. Curr Probl Cardiol. 2024;49(4): 102456.","journal-title":"Curr Probl Cardiol"},{"issue":"10","key":"2521_CR30","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk GD, Karwi QG, Tian R, Wende AR, Abel ED. Cardiac energy metabolism in heart failure. Circ Res. 2021;128(10):1487\u2013513.","journal-title":"Circ Res"},{"issue":"3","key":"2521_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(18)30136-0","volume":"7","author":"A Ceriello","year":"2019","unstructured":"Ceriello A, Monnier L, Owens D. Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol. 2019;7(3):221\u201330.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2521_CR32","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12933-020-01134-0","volume":"19","author":"DY Lee","year":"2020","unstructured":"Lee DY, Han K, Park S, Yu JH, Seo JA, Kim NH, Yoo HJ, Kim SG, Choi KM, Baik SH, Park YG, Kim NH. Glucose variability and the risks of stroke, myocardial infarction, and all-cause mortality in individuals with diabetes: retrospective cohort study. Cardiovasc Diabetol. 2020;19(1):144.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2521_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12933-020-01112-6","volume":"19","author":"CD Yang","year":"2020","unstructured":"Yang CD, Shen Y, Ding FH, Yang ZK, Hu J, Shen WF, Zhang RY, Lu L, Wang XQ. Visit-to-visit fasting plasma glucose variability is associated with left ventricular adverse remodeling in diabetic patients with STEMI. Cardiovasc Diabetol. 2020;19(1):131.","journal-title":"Cardiovasc Diabetol"},{"key":"2521_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.108942","volume":"178","author":"N Barzegar","year":"2021","unstructured":"Barzegar N, Ramezankhani A, Tohidi M, Azizi F, Hadaegh F. Long-term glucose variability and incident cardiovascular diseases and all-cause mortality events in subjects with and without diabetes: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract. 2021;178: 108942.","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"2521_CR35","first-page":"543","volume":"12","author":"C Liu","year":"2012","unstructured":"Liu C, Fu H, Li J, Yang W, Cheng L, Liu T, Li G. Hyperglycemia aggravates atrial interstitial fibrosis, ionic remodeling and vulnerability to atrial fibrillation in diabetic rabbits. Anadolu Kardiyol Derg. 2012;12(7):543\u201350.","journal-title":"Anadolu Kardiyol Derg"},{"issue":"1","key":"2521_CR36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/cvr\/cvu176","volume":"104","author":"S Saito","year":"2014","unstructured":"Saito S, Teshima Y, Fukui A, Kondo H, Nishio S, Nakagawa M, Saikawa T, Takahashi N. Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats. Cardiovasc Res. 2014;104(1):5\u201314.","journal-title":"Cardiovasc Res."},{"issue":"9","key":"2521_CR37","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1161\/CIRCRESAHA.114.303772","volume":"114","author":"P-S Chen","year":"2014","unstructured":"Chen P-S, Chen LS, Fishbein MC, Lin S-F, Nattel S. Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy. Circ Res. 2014;114(9):1500\u201315.","journal-title":"Circ Res"},{"issue":"4","key":"2521_CR38","doi-asserted-by":"publisher","first-page":"682","DOI":"10.2337\/dc14-0654","volume":"38","author":"J Fleischer","year":"2015","unstructured":"Fleischer J, Lebech Cichosz S, Hoeyem P, Laugesen E, Loegstrup Poulsen P, Sandahl Christiansen J, Tarnow L, Hansen TK. Glycemic variability is associated with reduced cardiac autonomic modulation in women with type 2 diabetes. Diabetes Care. 2015;38(4):682\u20138.","journal-title":"Diabetes Care"},{"key":"2521_CR39","doi-asserted-by":"crossref","unstructured":"Vrachatis DA, Papathanasiou KA, Kossyvakis C, Giotaki SG, Raisakis K, Iliodromitis KE, Reimers B, Stefanini GG, Cleman M, Sianos G, Lansky A, Deftereos SG, Giannopoulos G. Atrial fibrillation risk in patients suffering from type I diabetes mellitus. A review of clinical and experimental evidence. Diabetes Res Clin Pract. 2021;174.","DOI":"10.1016\/j.diabres.2021.108724"},{"key":"2521_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.946313","volume":"13","author":"LT Al Kury","year":"2022","unstructured":"Al Kury LT, Chacar S, Alefishat E, Khraibi AA, Nader M. Structural and electrical remodeling of the sinoatrial node in diabetes: new dimensions and perspectives. Front Endocrinol (Lausanne). 2022;13: 946313.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2521_CR41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12933-021-01232-7","volume":"20","author":"AS Papazoglou","year":"2021","unstructured":"Papazoglou AS, Kartas A, Samaras A, Vouloagkas I, Vrana E, Moysidis DV, Akrivos E, Kotzampasis G, Baroutidou A, Papanastasiou A, Liampas E, Botis M, Karagiannidis E, Stalikas N, Karvounis H, Tzikas A, Giannakoulas G. Prognostic significance of diabetes mellitus in patients with atrial fibrillation. Cardiovasc Diabetol. 2021;20(1):40.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"2521_CR42","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/clc.22801","volume":"40","author":"A Akirov","year":"2017","unstructured":"Akirov A, Grossman A, Shochat T, Shimon I. Hyperglycemia on admission and hospitalization outcomes in patients with atrial fibrillation. Clin Cardiol. 2017;40(11):1123\u20138.","journal-title":"Clin Cardiol"},{"issue":"6","key":"2521_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198533","volume":"13","author":"MA Sim","year":"2018","unstructured":"Sim MA, Liu W, Chew STH, Ti LK. Wider perioperative glycemic fluctuations increase risk of postoperative atrial fibrillation and ICU length of stay. PLoS ONE. 2018;13(6): e0198533.","journal-title":"PLoS ONE"},{"key":"2521_CR44","doi-asserted-by":"crossref","unstructured":"Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S111-S24","DOI":"10.2337\/dc21-S009"},{"issue":"1","key":"2521_CR45","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41572-024-00563-5","volume":"10","author":"IJ Neeland","year":"2024","unstructured":"Neeland IJ, Lim S, Tchernof A, Gastaldelli A, Rangaswami J, Ndumele CE, Powell-Wiley TM, Despr\u00e9s J-P. Metabolic syndrome. Nat Rev Dis Primers. 2024;10(1):77.","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"2521_CR46","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/s42255-024-01079-8","volume":"6","author":"O Le Thuc","year":"2024","unstructured":"Le Thuc O, Garc\u00eda-C\u00e1ceres C. Obesity-induced inflammation: connecting the periphery to the brain. Nat Metab. 2024;6(7):1237\u201352.","journal-title":"Nat Metab"},{"issue":"1","key":"2521_CR47","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s13054-019-2663-7","volume":"23","author":"S Lambden","year":"2019","unstructured":"Lambden S, Laterre PF, Levy MM, Francois B. The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Crit Care (London, England). 2019;23(1):374.","journal-title":"Crit Care (London, England)"},{"issue":"1","key":"2521_CR48","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13054-017-1930-8","volume":"22","author":"R Haniffa","year":"2018","unstructured":"Haniffa R, Isaam I, De Silva AP, Dondorp AM, De Keizer NF. Performance of critical care prognostic scoring systems in low and middle-income countries: a systematic review. Crit Care (London, England). 2018;22(1):18.","journal-title":"Crit Care (London, England)"},{"key":"2521_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2024.100507","volume":"31","author":"Y Chen","year":"2024","unstructured":"Chen Y, Huang B, Calvert P, Liu Y, Gue Y, Gupta D, McDowell G, Azariah JL, Namboodiri N, Unni G, Balagopalan JP, Lip GYH, Gopalan BC, Namboodiri N, Jabir A, George Koshy A, Zachariah G, Shifas Babu M, Venugopal K, Punnose E, Natarajan KU, Joseph J, Ashokan Nambiar C, Jayagopal PB, Mohanan PP, George R, Unni G, Sajeev CG, Syam N, Roby A, Daniel R, Krishnakumar VV, Pillai AM, Joseph S, Mini GK, Koya SF, Eapen K, Ram R, Mathew C, Faizal A, Issac B, Renga S, Menon J, Harikrishna D, Suresh K, Nair T, Susanth SS, Kumar RA, Abilash TP, Sreekala P, Rajeev E, Raj A, Naik R, Rajalekshmi S, Gopinath A, Binu R, Chacko J, Iqbal PT, Sudhir NM, Sreedharan M, Balakrishnan N, Musthaffa M, Jayakumar B, George S, Kumar A, Mathew T, Pramod VK, Shaloob M, Chandy MP, Vinod KR, Das K, Ahamad ZS, Mathew P. Phenotypes of South Asian patients with atrial fibrillation and holistic integrated care management: cluster analysis of data from KERALA-AF Registry. Lancet Regional Health - Southeast Asia. 2024;31: 100507.","journal-title":"Lancet Regional Health - Southeast Asia"},{"key":"2521_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.730453","volume":"8","author":"Y Chen","year":"2021","unstructured":"Chen Y, Wu S, Ye J, Wu M, Xiao Z, Ni X, Wang B, Chen C, Chen Y, Tan X, Liu R. Predicting all-cause mortality risk in atrial fibrillation patients: a novel LASSO-Cox model generated from a prospective dataset. Front Cardiovasc Med. 2021;8: 730453.","journal-title":"Front Cardiovasc Med"},{"key":"2521_CR51","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ahj.2023.08.006","volume":"265","author":"A Bisson","year":"2023","unstructured":"Bisson A, Lemrini Y, Romiti GF, Proietti M, Angoulvant D, Bentounes S, El-Bouri W, Lip GYH, Fauchier L. Prediction of early death after atrial fibrillation diagnosis using a machine learning approach: a French nationwide cohort study. Am Heart J. 2023;265:191\u2013202.","journal-title":"Am Heart J"},{"issue":"5","key":"2521_CR52","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.hjc.2021.01.007","volume":"62","author":"A Samaras","year":"2021","unstructured":"Samaras A, Kartas A, Akrivos E, Fotos G, Dividis G, Vasdeki D, Vrana E, Rampidis G, Karvounis H, Giannakoulas G, Tzikas A. A novel prognostic tool to predict mortality in patients with atrial fibrillation: the BASIC-AF risk score. Hellenic J Cardiol. 2021;62(5):339\u201348.","journal-title":"Hellenic J Cardiol"},{"issue":"5","key":"2521_CR53","doi-asserted-by":"publisher","first-page":"919","DOI":"10.2337\/dc18-2149","volume":"42","author":"T Danne","year":"2019","unstructured":"Danne T, Cariou B, Buse JB, Garg SK, Rosenstock J, Banks P, Kushner JA, McGuire DK, Peters AL, Sawhney S, Strumph P. Improved time in range and glycemic variability with sotagliflozin in combination with insulin in adults with type 1 diabetes: a pooled analysis of 24-week continuous glucose monitoring data from the in Tandem Program. Diabetes Care. 2019;42(5):919\u201330.","journal-title":"Diabetes Care"},{"issue":"11","key":"2521_CR54","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.jacep.2022.08.004","volume":"8","author":"H Kishima","year":"2022","unstructured":"Kishima H, Mine T, Fukuhara E, Kitagaki R, Asakura M, Ishihara M. Efficacy of sodium-glucose cotransporter 2 inhibitors on outcomes after catheter ablation for atrial fibrillation. JACC Clin Electrophysiol. 2022;8(11):1393\u2013404.","journal-title":"JACC Clin Electrophysiol"},{"key":"2521_CR55","doi-asserted-by":"crossref","unstructured":"Fichadiya A, Quinn A, Au F, Campbell D, Lau D, Ronksley P, Beall R, Campbell DJT, Wilton SB, Chew DS. Association between sodium-glucose cotransporter-2 inhibitors and arrhythmic outcomes in patients with diabetes and pre-existing atrial fibrillation. Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 2024;26(3).","DOI":"10.1093\/europace\/euae054"},{"issue":"3","key":"2521_CR56","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15005","volume":"40","author":"OG Mustafa","year":"2023","unstructured":"Mustafa OG, Haq M, Dashora U, Castro E, Dhatariya KK. Management of Hyperosmolar Hyperglycaemic State (HHS) in adults: an updated guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care Group. Diabet Med. 2023;40(3): e15005.","journal-title":"Diabet Med"},{"issue":"1","key":"2521_CR57","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12864-024-10197-2","volume":"25","author":"Y Wu","year":"2024","unstructured":"Wu Y, Kong X-J, Ji Y-Y, Fan J, Ji C-C, Chen X-M, Ma Y-D, Tang A-L, Cheng Y-J, Wu S-H. Serum electrolyte concentrations and risk of atrial fibrillation: an observational and mendelian randomization study. BMC Genom. 2024;25(1):280.","journal-title":"BMC Genom"},{"issue":"40","key":"2521_CR58","doi-asserted-by":"publisher","first-page":"5032","DOI":"10.1039\/C8CC01678J","volume":"54","author":"BJ van Enter","year":"2018","unstructured":"van Enter BJ, von Hauff E. Challenges and perspectives in continuous glucose monitoring. Chem Commun (Camb). 2018;54(40):5032\u201345.","journal-title":"Chem Commun (Camb)"},{"issue":"7","key":"2521_CR59","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41574-024-00973-1","volume":"20","author":"RA Ajjan","year":"2024","unstructured":"Ajjan RA, Battelino T, Cos X, Del Prato S, Philips J-C, Meyer L, Seufert J, Seidu S. Continuous glucose monitoring for the routine care of type 2 diabetes mellitus. Nat Rev Endocrinol. 2024;20(7):426\u201340.","journal-title":"Nat Rev Endocrinol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02521-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-024-02521-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02521-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T06:07:07Z","timestamp":1732601227000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-024-02521-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2521"],"URL":"https:\/\/doi.org\/10.1186\/s12933-024-02521-7","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,26]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The BIDMC Institutional Review Board approved the ethical review and approved the sharing plan (2001-P-001699\/14; No.0403000206). All data used in this study were anonymised prior to use and analysed retrospectively only, therefore no additional written informed consent was required. All procedures involving human participants in this study followed the ethical standards of the Institutional and National Research Councils, as well as the 1964 Declaration of Helsinki and its subsequent amendments or similar ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"426"}}